NDC 54925-032 - TRI OTIC
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 54925-032
- Package NDCs from labels
- 54925-032-75, 54925-032-15, 54925-032-10, 54925-032-45, 54925-032-25, 54925-032-40
- Manufacturer
- Med-Pharmex, Inc
- Effective date
- 2023-07-14
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| TRI OTIC - Med-Pharmex, Inc | Med-Pharmex, Inc | 2023-07-14 | PRESCRIPTION ANIMAL DRUG LABEL |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| BETAMETHASONE VALERATE | ACTIVE INGREDIENT | 9IFA5XM7R2 | TRI OTIC (GENTAMICIN SULFATE, BETAMETHASONE VALERATE, AND CLOTRIMAZOLE ) OINTMENT [MED-PHARMEX, INC] | 2 | |
| CLOTRIMAZOLE | ACTIVE INGREDIENT | G07GZ97H65 | TRI OTIC (GENTAMICIN SULFATE, BETAMETHASONE VALERATE, AND CLOTRIMAZOLE ) OINTMENT [MED-PHARMEX, INC] | 2 | |
| GENTAMICIN SULFATE | ACTIVE INGREDIENT | 8X7386QRLV | TRI OTIC (GENTAMICIN SULFATE, BETAMETHASONE VALERATE, AND CLOTRIMAZOLE ) OINTMENT [MED-PHARMEX, INC] | 2 | |
| BETAMETHASONE | ACTIVE MOIETY | 9842X06Q6M | TRI OTIC (GENTAMICIN SULFATE, BETAMETHASONE VALERATE, AND CLOTRIMAZOLE ) OINTMENT [MED-PHARMEX, INC] | 2 | |
| CLOTRIMAZOLE | ACTIVE MOIETY | G07GZ97H65 | TRI OTIC (GENTAMICIN SULFATE, BETAMETHASONE VALERATE, AND CLOTRIMAZOLE ) OINTMENT [MED-PHARMEX, INC] | 2 | |
| GENTAMICIN | ACTIVE MOIETY | T6Z9V48IKG | TRI OTIC (GENTAMICIN SULFATE, BETAMETHASONE VALERATE, AND CLOTRIMAZOLE ) OINTMENT [MED-PHARMEX, INC] | 2 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Tuymec Antifungal Medicated Bar | ANTIFUNGAL MEDICATED BAR | Guangzhou Jingliang Cosmetics Co., Ltd. | 4a8265c5-9c69-a36a-e063-6294a90ab292 | 2026-02-11 | Warnings | G07GZ97H65 |
| Kerova ANTIFUNGAL | CLOTRIMAZOLE | Guangzhou Bixiaoyu Trading Co., Ltd. | 4a7b48cf-72c3-be63-e063-6394a90a1efe | 2026-02-10 | Warnings | G07GZ97H65 |
| Kerova Clotrimazole | ANTIFUNGAL | Guangzhou Bixiaoyu Trading Co., Ltd. | 4a7b9658-f411-299d-e063-6394a90af9ce | 2026-02-10 | Warnings | G07GZ97H65 |
| CLOTRIMAZOLE 1% | CLOTRIMAZOLE | PHARMACY CHOICE INC | 43852cfb-6d28-e54f-e063-6394a90aa090 | 2026-02-08 | Warnings | G07GZ97H65 |
| HEALMUSZ Clotrimazole | CLOTRIMAZOLE1% MICONAZOLE1% CLOTRIMAZOLE | Jiangxi Yudexi Pharmaceutical Co., LTD | 4a326159-a6a7-c1d6-e063-6294a90a3b89 | 2026-02-06 | Warnings | G07GZ97H65 |
| BETAMETHASONE VALERATE | BETAMETHASONE VALERATE | A-S Medication Solutions | 7281d272-5342-4738-b35c-42570459e9d4 | 2026-02-04 | Adverse reactions | 9IFA5XM7R2 |
| Clotrimazole | CLOTRIMAZOLE | Glenmark Pharmaceuticals Inc., USA | f6898117-14f3-42d2-bc0e-d296add3ad70 | 2026-01-30 | Warnings, Adverse reactions | G07GZ97H65 |
| Jock Itch Clotrimazole Antifungal | CLOTRIMAZOLE | WalMart | a7677ad4-5239-40da-809a-501b91caedbf | 2026-01-29 | Warnings | G07GZ97H65 |
| Gentamicin | GENTAMICIN | Eugia US LLC | 60ca1487-392d-4721-aa45-3de38722896c | 2026-01-29 | Boxed warning, Warnings, Adverse reactions | 8X7386QRLV |
| Clotrimazole | CLOTRIMAZOLE | A-S Medication Solutions | bac80746-5cc3-4910-a0af-d43b8242acc6 | 2026-01-29 | Warnings | G07GZ97H65 |
| Betamethasone Valerate | BETAMETHASONE VALERATE | E. Fougera & Co. a division of Fougera Pharmaceuticals, LLC | 0b386ccc-a2d4-4d18-a2d7-e46ff894c674 | 2026-01-28 | Adverse reactions | 9IFA5XM7R2 |
| Gentamicin | GENTAMICIN | Eugia US LLC | f8c608b3-50b8-4d5d-9e8a-e92c0d2e3cdc | 2026-01-27 | Boxed warning, Warnings, Adverse reactions | 8X7386QRLV |
| clotrimazole | CLOTRIMAZOLE | Padagis Israel Pharmaceuticals Ltd | 3dcd0158-ec51-4fa7-a26a-02c2926156c0 | 2026-01-22 | Warnings | G07GZ97H65 |
| Clotrimazole Topical Solution USP, 1% | CLOTRIMAZOLE TOPICAL SOLUTION USP, 1% | TruPharma LLC | 1d2354f2-edfd-4be7-9550-760958eb36ee | 2026-01-18 | Warnings, Adverse reactions | G07GZ97H65 |
| Clotrimazole and Betamethasone Dipropionate | CLOTRIMAZOLE AND BETAMETHASONE DIPROPIONATE | A-S Medication Solutions | 2eff5585-f013-42f0-b678-bb5406e8188c | 2026-01-09 | Warnings, Adverse reactions | G07GZ97H65 |
| Clotrimazole | CLOTRIMAZOLE | The Podiatree Company | 68a4e3f5-f84d-5650-e053-2a91aa0a171d | 2026-01-08 | Warnings | G07GZ97H65 |
| Clotrimazole | CLOTRIMAZOLE | The Podiatree Company | 79234400-0766-792c-e053-2a91aa0a6e6d | 2026-01-08 | Warnings | G07GZ97H65 |
| Fortinia | CLOTRIMAZOLE 1% | The Podiatree Company | a003130b-77f7-4d42-8e7f-edd55176f013 | 2026-01-08 | Warnings | G07GZ97H65 |
| Fortinia OF | CLOTRIMAZOLE 1% | The Podiatree Company | 60cbd3aa-9ad7-24e4-e053-2a91aa0ab05f | 2026-01-08 | Warnings | G07GZ97H65 |
| Fortinia | CLOTRIMAZOLE | The Podiatree Company | 60ba6f8a-8617-d4f6-e053-2991aa0a4a71 | 2026-01-08 | Warnings | G07GZ97H65 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.